Search Orphan Drug Designations and Approvals
-
| Generic Name: | Human monoclonal antibody against phosphorylcholine |
|---|---|
| Date Designated: | 06/15/2017 |
| Orphan Designation: | Prevention of arteriovenous fistula or arteriovenous graft failure in patients with end stage renal disease receiving hemodialysis or preparing for hemodialysis |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Athera Biotechnologies, AB 117 Sankt Eriksgatan 4th Floor Norrmalm, Stockholms län Sweden The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







